These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11760782)

  • 21. Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder.
    Orgen S; Deliktas H; Sahin H; Gedik A; Nergis Y
    Low Urin Tract Symptoms; 2017 Jan; 9(1):52-56. PubMed ID: 28120444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program Resource].
    Krivoborodov GG; Tur EI; Efremov NS; Shkolnikov ME
    Urologiia; 2016 Aug; (4):29-34. PubMed ID: 28247723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial.
    Cardozo L; Chapple CR; Toozs-Hobson P; Grosse-Freese M; Bulitta M; Lehmacher W; Strösser W; Ballering-Brühl B; Schäfer M
    BJU Int; 2000 Apr; 85(6):659-64. PubMed ID: 10759661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system.
    Todorova A; Vonderheid-Guth B; Dimpfel W
    J Clin Pharmacol; 2001 Jun; 41(6):636-44. PubMed ID: 11402632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults.
    Oefelein MG; Tong W; Kerr S; Bhasi K; Patel RK; Yu D
    Clin Drug Investig; 2013 Feb; 33(2):123-31. PubMed ID: 23325481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
    Staskin DR
    Urol Clin North Am; 2006 Nov; 33(4):465-73, viii. PubMed ID: 17011382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The basis for drug treatment of the overactive bladder.
    Andersson KE; Chapple C; Wein A
    World J Urol; 2001 Nov; 19(5):294-8. PubMed ID: 11760776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
    Staskin DR; Rosenberg MT; Sand PK; Zinner NR; Dmochowski RR
    Int J Clin Pract; 2009 Dec; 63(12):1715-23. PubMed ID: 19930332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological effects of tolterodine on human isolated urinary bladder.
    Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
    Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxybutynin and the overactive bladder.
    Andersson KE; Chapple CR
    World J Urol; 2001 Nov; 19(5):319-23. PubMed ID: 11760780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
    Kosilov K; Loparev S; Ivanovskaya M; Kosilova L
    Aging Male; 2015 Mar; 18(1):44-8. PubMed ID: 25136746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
    Sand PK; Johnson Ii TM; Rovner ES; Ellsworth PI; Oefelein MG; Staskin DR
    BJU Int; 2011 Feb; 107(4):612-20. PubMed ID: 20707790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New once-daily formulation for trospium in overactive bladder.
    Chapple C
    Int J Clin Pract; 2010 Oct; 64(11):1535-1540. PubMed ID: 20846201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tolterodine and trospium chloride on renal damage induced by partial upper urinary tract obstruction.
    Karaman A; Samdancı E; Sayın S; Karabulut I; Fadıllıoglu E
    Urology; 2013 Jul; 82(1):194-200. PubMed ID: 23453648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of trospium chloride on lower urinary tract function].
    Suzuki T; Nishizawa S; Sugaya K; Kohama T; Matsuzaki A; Fukuda T; Tsukada O; Harada T; Tsuchida M
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):372-5. PubMed ID: 2702295
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat.
    Woods M; Carson N; Norton NW; Sheldon JH; Argentieri TM
    J Urol; 2001 Sep; 166(3):1142-7. PubMed ID: 11490313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxybutynin and trospium are substrates of the human organic cation transporters.
    Wenge B; Geyer J; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):203-8. PubMed ID: 21212936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.